Bioreactor Market Size Grows at CAGR of 12.1% & to Reach US$ 13.2 Billion by 2028
Bioreactor Market Overview 2023-2028:
IMARC Group’s latest research report,
titled “Bioreactor Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028,” the global bioreactor
market size reached US$ 6.5 Billion in 2022. Looking forward,
IMARC Group expects the market to reach US$ 13.2 Billion by 2028, exhibiting a
growth rate (CAGR) of 12.1% during 2023-2028.
Bioreactor Uses:
Bioreactors are manufacturing devices
in which biological reactions are executed and are used for organism's
cultivation growth, such as mammalian cells, bacteria, yeast cells, and animal
cells under controlled conditions. They support a sustainable environment
for cell growth and product formation. These are mainly used in
industrial processes for pharmaceutical products, including vaccines and
monoclonal antibodies, among other products. They are also widely
utilized in industrial processes to cultivate organisms under controlled
conditions and produce pharmaceutical products to treat chronic diseases.
Request Free Sample Report (Exclusive
Offer on this report): https://www.imarcgroup.com/bioreactor-market/requestsample
What is the Role of Bioreactor in Industry ? :
The global market is majorly driven by
increasing demand for monoclonal antibiotics. In line with this, rising
funding from government and private organizations for vaccine development is
significantly contributing to global market growth. Furthermore, growing
demand for single-use bioreactors; and rapid development in the pharmaceutical
and biotechnology industry are positively influencing the market growth.
Apart from this, escalating Prevalence of several chronic conditions such as
cardiovascular disorders, cancer, and diabetes is increasing the production of
associated therapeutics, catalyzing the market expansion. Moreover,
increasing research and development activities to cater to efficient novel
therapies in cancer treatment is propelling industry growth. Besides, the
growing demand for personalized medicine and shifting focus on orphan drug
development is favoring the market growth. Additionally, multiple market
players are involved in developing advanced technology, such as inbuilt
bioreactors with cost-effectiveness to deliver large-scale manufacturing, which
will strengthen the product demand.
Key Players Included in
Global Bioreactor Market Research Report:
- 2mag AG
- bbi-biotech GmbH
- Bioengineering AG
- Eppendorf SE
- Getinge AB
- Infors AG
- Merck KGaA
- Pall Corporation (Danaher Corporation)
- Sartorius AG
- Solaris Biotechnology Srl
- Thermo Fisher Scientific Inc
Ask Analyst for Instant Discount and
Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/bioreactor-market
Key Market Segmentation:
Breakup by Product Type:
- Glass
- Stainless Steel
- Single-Use
Breakup by Usage:
- Lab-Scale Production
- Pilot-Scale Production
- Full-Scale Production
Breakup by Scale:
- 5L-20L
- 20L-200L
- 200L-1500L
- Above 1500L
Breakup by Control Type:
- Manual
- Automated
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea,
Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar,
Iraq, Other)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Related Report By IMARC Group:
- Bio-Based Polyethylene Market Overview 2023
- Biogas Market Overview 2023
- Beverage Packaging Market Overview 2023
- Biomarker Technologies Market Overview 2023
- Bone Graft And Substitutes Market Overview 2023
About Us:
IMARC Group is a leading market
research company that offers management strategy and market research worldwide.
We partner with clients in all sectors and regions to identify their
highest-value opportunities, address their most critical challenges, and transform
their businesses.
IMARC’s information products include
major market, scientific, economic and technological developments for business
leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and tourism, nanotechnology and
novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800